HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Severe mechanical haemolysis after correction of a partial atrioventricular canal (author's transl)].

Abstract
Following correction of a partial atrioventricular canal and closure of the atrial septum defect with a Dacron patch a severe hemolytic anemia developed caused by moderate mitral insufficiency. The clinical postoperative course and the successful treatment by reoperation is described in detail. The Dacron patch was excised, the mitral cleft was closed by four single sutures, and the septal defect was covered with a pericardial patch. In the literature ten other communications were gathered reporting hemolytic anemias following correction of endocardial cushion defects with Dacron, Teflon, or Ivalon patches. Three of six reoperated patients died postoperatively. A woman died after correction with renal failure caused by severe hemolysis. In four patients hemolytic anemia was compensated and there was no need for reoperation. In consideration of our own experience and those reported in the literature we recommend pericardium instead of synthetics for closure of atrial septum defects of Foramen-primum-type.
AuthorsH D Schulte, E Sygula, M Bourgeois, W Pöttgen, L Seipel
JournalThoraxchirurgie, vaskulare Chirurgie (Thoraxchir Vask Chir) Vol. 26 Issue 2 Pg. 117-23 (Apr 1978) ISSN: 0040-6384 [Print] Germany
Vernacular TitleSchwere mechanische Hämolyse nach Korrektur eines partiellen atrioventrikulären Kanals.
PMID653702 (Publication Type: English Abstract, Journal Article)
Topics
  • Anemia, Hemolytic (diagnosis, etiology)
  • Child
  • Heart Septal Defects, Atrial (surgery)
  • Humans
  • Male
  • Mitral Valve Insufficiency (complications)
  • Postoperative Complications (diagnosis, etiology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: